---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-029190"
form_type: "8-K"
ticker: null
cik: "0001531048"
company_name: "Inari Medical, Inc."
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T11:38:20.794934+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Stryker completes $4.94B acquisition of Inari Medical; shares delisted

## Summary
- Tender offer accepted 48.5M shares (81.69%) at $80.00/share; merger closed under DGCL 251(h).
- Total aggregate consideration ~$4.94B cash; funded from Stryker cash and debt.
- Inari Board resigned; William E. Berry Jr. and J. Andrew Pierce appointed directors; officers remain.
- Shares to be delisted from Nasdaq; Form 15 to be filed to suspend SEC reporting.

## SEC filing metadata
- accession: 0001193125-25-029190
- form_type: 8-K
- cik: 0001531048
- company_name: Inari Medical, Inc.
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.02, 2.01, 3.01, 5.01, 5.03, 3.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/d932380d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-029190
- JSON: https://secwatch.observer/filing/0001193125-25-029190.json
- Plain text: https://secwatch.observer/filing/0001193125-25-029190.txt

## Key facts
- Executive change
  Andrew Hykes resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Robert K. Warner resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  J. Andrew Pierce was appointed as Director at Inari Medical, Inc..
  - Action: appointed
  - Role: Director
  source text: the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  William E. Berry Jr. was appointed as Director at Inari Medical, Inc..
  - Action: appointed
  - Role: Director
  source text: the directors of Merger Sub as of immediately prior to the Effective Time, William E. Berry Jr. and J. Andrew Pierce, became the directors of the Surviving Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Bill Hoffman resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Jonathan Root resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Donald Milder resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Dana G. Mead, Jr. resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Catherine Szyman resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Cynthia Lucchese resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Executive change
  Rebecca Chambers resigned as Director at Inari Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: Donald Milder, Jonathan Root, Cynthia Lucchese, Catherine Szyman, Bill Hoffman, Rebecca Chambers, Dana G. Mead, Jr., Robert K. Warner and Andrew Hykes each resigned from his or her respective position as a member of the Inari Board of Directors and any committee thereof.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Governance Changes
  Inari Medical, Inc.: Inari's certificate of incorporation was amended and restated in its entirety as of the Effective Time pursuant to the Merger Agreement.
  - Change: charter amendment
  source text: as of the Effective Time, Inari’s certificate of incorporation was amended and restated in its entirety.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- Governance Changes
  Inari Medical, Inc.: Inari's bylaws were amended and restated in their entirety as of the Effective Time pursuant to the Merger Agreement.
  - Change: bylaw amendment
  source text: as of the Effective Time, Inari’s bylaws were amended and restated in their entirety.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- M&A Transactions
  Inari Medical, Inc. underwent a change of control involving Stryker Corporation for $80.00 per Share, net to the seller in cash (closed 2025-02-19).
  - Action: change of control
  - Counterparty: Stryker Corporation
  - Consideration: $80.00 per Share, net to the seller in cash
  - Closing: 2025-02-19
  source text: commenced a tender offer (the “ Offer ”) to purchase all of the issued and outstanding shares of Inari’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $80.00 per Share, net to the seller in cash, without interest and subject to any applicable tax withholding (the “ Offer Consideration ”). The Offer expired as scheduled at one minute
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm
- M&A Transactions
  Inari Medical, Inc. completed a disposition involving Stryker Corporation for approximately $4.94 billion in cash (closed 2025-02-19).
  - Action: disposition
  - Counterparty: Stryker Corporation
  - Consideration: approximately $4.94 billion in cash
  - Closing: 2025-02-19
  source text: The total aggregate consideration paid by Merger Sub in the transaction was approximately $4.94 billion in cash.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000119312525029190/0001193125-25-029190-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.